Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin.

Kwan D, Bartle WR, Walker SE.

J Clin Pharmacol. 1999 Jan;39(1):68-75.

PMID:
9987702
2.

Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin.

Kong AN, Tomasko L, Waldman SA, Osborne B, Deutsch PJ, Goldberg MR, Bjornsson TD.

J Clin Pharmacol. 1995 Oct;35(10):1008-15.

PMID:
8568008
3.
4.

Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.

Washington C, Hou SY, Hughes NC, Campanella C, Berner B.

J Clin Pharmacol. 2007 Oct;47(10):1320-6. Epub 2007 Aug 27.

PMID:
17724088
5.

The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.

Zhi J, Melia AT, Guerciolini R, Koss-Twardy SG, Passe SM, Rakhit A, Sadowski JA.

J Clin Pharmacol. 1996 Jul;36(7):659-66.

PMID:
8844450
6.
7.

The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans.

Niopas I, Toon S, Aarons L, Rowland M.

Eur J Clin Pharmacol. 1999 Jul;55(5):399-404.

PMID:
10456491
8.
9.

The stereoselective effects of bucolome on the pharmacokinetics and pharmacodynamics of racemic warfarin.

Matsumoto K, Ishida S, Ueno K, Hashimoto H, Takada M, Tanaka K, Kamakura S, Miyatake K, Shibakawa M.

J Clin Pharmacol. 2001 Apr;41(4):459-64.

PMID:
11304904
10.

Effect of the endothelin-receptor antagonist bosentan on the pharmacokinetics and pharmacodynamics of warfarin.

Weber C, Banken L, Birnboeck H, Schulz R.

J Clin Pharmacol. 1999 Aug;39(8):847-54.

PMID:
10434238
11.

Stereochemical aspects of warfarin drug interactions: use of a combined pharmacokinetic-pharmacodynamic model.

Chan E, McLachlan A, O'Reilly R, Rowland M.

Clin Pharmacol Ther. 1994 Sep;56(3):286-94.

PMID:
7924124
12.

Enzymatic shunting: resolving the acetaminophen-warfarin controversy.

Lehmann DE.

Pharmacotherapy. 2000 Dec;20(12):1464-8. Review.

PMID:
11130219
13.

Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.

Krishna R, Stypinski D, Ali M, Garg A, Cote J, Maes A, Degroot B, Liu Y, Li S, Connolly SM, Wagner JA, Stoch SA.

Br J Clin Pharmacol. 2012 Jul;74(1):116-24. doi: 10.1111/j.1365-2125.2012.04171.x.

14.

Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers.

Liao S, Palmer M, Fowler C, Nayak RK.

J Clin Pharmacol. 1996 Nov;36(11):1072-7.

PMID:
8973996
15.

Absence of a pharmacokinetic interaction between etanercept and warfarin.

Zhou H, Patat A, Parks V, Buckwalter M, Metzger D, Korth-Bradley J.

J Clin Pharmacol. 2004 May;44(5):543-50.

PMID:
15102876
16.

Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.

Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ.

Br J Clin Pharmacol. 2004 May;57(5):592-9. Erratum in: Br J Clin Pharmacol. 2004 Jul;58(1):102.

17.

Divergent effects of raloxifene HCI on the pharmacokinetics and pharmacodynamics of warfarin.

Miller JW, Skerjanec A, Knadler MP, Ghosh A, Allerheiligen SR.

Pharm Res. 2001 Jul;18(7):1024-8.

PMID:
11496940
18.

Investigations into the potential effects of multiple dose ketorolac on the pharmacokinetics and pharmacodynamics of racemic warfarin.

Toon S, Holt BL, Mullins FG, Bullingham R, Aarons L, Rowland M.

Br J Clin Pharmacol. 1990 Nov;30(5):743-50.

20.

Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin.

Ragueneau-Majlessi I, Levy RH, Meyerhoff C.

Epilepsy Res. 2001 Nov;47(1-2):55-63.

PMID:
11673021

Supplemental Content

Support Center